Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Admelog vs Humalog in T1DM Pump Users
NCT02603510Phase 1Completed
- Sponsor
- Sanofi
- Start
- Nov 2015
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of insulin lispro in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Frequency of infusion set occlusions at 4 weeks. Started Nov 2015; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02603510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603510.